March 11 /2015 Emerging MarketsSouth Africa's BioScience Bounty Pfizer recently hosted a delegation of start-up entrepreneurs and R&D "incubator" executives with the aim to identify actions to break the logjams around great science through a sustainable network of private-sector bioscience enterprises — particularly in emerging market countries like South Africa, where useful precedents exist on delivering health innovations at lower cost to society ... /Read more/ |
||||||||
| EU Stamping on MAPPs: Is Europe Trapped Again by Division? Just as everyone is starting to talk about MAPPs – medicine adaptive pathways to patients – the European Union has come up with STAMP – a new expert group ostensibly intended to assist the MAPPs process, but which, in its current manifestation, appears just as likely to suffocate it. Reflector reports... /Read more/ |
||||||||
| UK Pricing The NICE Threshold Debate Heats Up The small matter of just what is the threshold for cost effectiveness has never been straightforward. The history of the threshold in the UK is one of first denying that one existed, to recognition formally that it did — but with a range from £20,000 to £30,000 ($30,850 to $46,280) per Quality Adjusted Life Year (QALY). Now, more research by the National Institute for Health and Research and the Medical Research Council point to an even lower threshold. Leela Barham reports ... /Read more/ |
||||||||
| Advertorial So What is Pharma's Ideal Role in Social? Patients and Healthcare Professionals (HCPs) are active on social media and closed community forums, but Pharma is relatively inactive. But with social media conversations undoubtedly influencing patients and physicians, what role should pharma take in the conversation? ... /Read more/ |
||||||||
| Leadership Pharm Exec's Emerging Pharma Leaders 2015: Nominate Now! It's time for you to tell us who you think should receive Pharm Exec's 2015 Emerging Pharma Leadership Award. Read more for details of how to nominate a colleague — or yourself ... /Read more/ |
Forecast Pharm Exec's 2015 Industry Outlook Pharm Exec's annual report highlights the key scientific, commercial, and reputational trends shaping the industry in the year ahead ... /Read more/ |
|||||||
industry update
|
 |
|
 |
|
|
|
 |
 |
 |
 |
 |
 |